Sign up
Pharma Capital

Significant pharma interest as IXICO showcases technology at Alzheimer’s conference

John Hall, senior vice president of commercial operations at IXICO Plc (LON:IXI) talks Proactive through their recent attendance at the Alzheimer's Association International conference and why it's important they were there.

Hall also discusses their own Expert Symposium as well as the growing opportunities in the application of wearable biosensors.


View full IXI profile View Profile

IXICO bags a £1mln contract

View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.